Loading...
•
Dec 31, 2021
ClearPoint Neuro Q4 2021 Earnings Report
Reported record revenues, overcoming elective procedure disruptions and supply chain issues.
Key Takeaways
ClearPoint Neuro reported a 15% increase in total revenue for Q4 2021, reaching $4.3 million compared to $3.7 million in Q4 2020. The company's cash and cash equivalents totaled $54.1 million.
Total revenue increased by 15% to $4.3 million.
Functional neurosurgery navigation revenue increased by 37% to $2.1 million.
Biologics and drug delivery revenue increased by 10% to $1.7 million.
Cash and cash equivalents totaled $54.1 million.
Revenue by Segment
Forward Guidance
The company expects revenue in 2022 in the range of $20 to $22 million.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...